Bcl-2 polymorphism influences gray matter volume in the ventral striatum in healthy humans

Biological Psychiatry

Volumn 66, Issue 8, 2009, Pages 804-807

  Salvadore, Giacomo ^a   Nugent, Allison C ^a   Chen, Guang ^a   Akula, Nirmala ^a   Yuan, Peixiong ^a   Cannon, Dara M ^b   Zarate Jr , Carlos A ^a   McMahon, Francis J ^a   Manji, Husseini K ^a   Drevets, Wayne C ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

Accumbens; Magnetic resonance imaging; Neurogenetics; Neuroplasticity; Voxel based morphometry (VBM)

Indexed keywords

DNA; PROTEIN BCL 2;

ADULT; ARTICLE; BRAIN SIZE; CORPUS STRIATUM; GENETIC POLYMORPHISM; GENOTYPE; GRAY MATTER; HUMAN; MORPHOMETRICS; NERVE CELL PLASTICITY; NEUROIMAGING; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; VOXEL BASED MORPHOMETRY; WHITE MATTER; ALLELE; BASAL GANGLION; BRAIN; BRAIN MAPPING; FEMALE; GENETICS; HISTOLOGY; MALE; MIDDLE AGED; NERVE TRACT; ORGAN SIZE; PHYSIOLOGY; PROTO ONCOGENE;

ADULT; ALLELES; BASAL GANGLIA; BRAIN; BRAIN MAPPING; FEMALE; GENES, BCL-2; GENOTYPE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEURAL PATHWAYS; ORGAN SIZE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 74049091824     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2009.05.025     Document Type: Article

References (20)

1. Chen G, Manji HK (2006): The extracellular signal-regulated kinase pathway: An emerging promising target for mood stabilizers. Curr Opin Psychiatry 19:313-323.
2. Chen DF, Schneider GE, Martinou JC, Tonegawa S (1997): Bcl-2 promotes regeneration of severed axons in mammalian CNS. Nature 385:435-439.
3. Jonas E (2006): Bcl-xl regulates synaptic plasticity. Mol Interv 6:208-222.
4. Manji HK (2008): Bcl-2: A key regulator of affective resilience in the pathophysiology and treatment of severe mood disorders. Biol Psychiatry 63(suppl 1):243S.
5. Yuan P,BaumAE, Zhou R,WangY, Laje G,McMahonFJ, et al. (2008): Bcl-2 polymorphisms associated with mood disorders and antidepressantresponsiveness regulate Bcl-2 gene expression and cellular resilience in human lymphoblastoid cell lines. Biol Psychiatry 63(suppl 1):63S.
6. Drevets WC, Price JL, Furey ML (2008): Brain structural and functional abnormalities inmooddisorders: Implications for neurocircuitry models of depression. Brain Struct Funct 213:93-118.
7. Frodl T, Koutsouleris N, Bottlender R, Born C, Jäger M, Mörgenthaler M, et al. (2008): Reduced gray matter brain volumes are associated with variants of the serotonin transporter gene in major depression. Mol Psychiatry 13:1093-1101.
8. Blumberg HP, Wang F, Chepenik LG, Kalmar JH, Edmiston E, Duman RS, et al. (2008): Influence of vascular endothelial growth factor variation on human hippocampus morphology. Biol Psychiatry 64:901-903.
9. Alexander GE, Crutcher MD, DeLong MR (1990): Basal ganglia- thalamocortical circuits: Parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions. Prog Brain Res 85:119-146.
10. First MB, Spitzer RL, Gibbon M, Williams JB (2002): Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Non-Patient Edition. New York: Biometrics Research Department, New York State Psychiatric Institute.
11. Good CD, Johnsrude IS, Ashburner J, Henson RN, Friston KJ, Frackowiak RS (2001): A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 14:21-36.
12. Talairach J, Tournoux P (1988): Co-Planar Stereotaxic Atlas of the Human Brain: 3-Dimensional Proportional System-An Approach to Cerebral Imaging. New York: Thieme Medical Publishers.
13. Nestler EJ, Carlezon WA Jr (2006): The mesolimbic dopamine reward circuit in depression. Biol Psychiatry 59:1151-1159.
14. Grace AA, Floresco SB, Goto Y, Lodge D (2007): Regulation of firing of dopaminergic neurons and control of goal-directed behaviors. Trends Neurosci 30:220-227.
15. FudgeJL,HaberSN(2002):Definingthe caudal ventral striatum in primates: Cellular and histochemical features. J Neurosci 22:10078-10082.
16. Vyas S, Javoy-Agid F, Herrero MT, Strada O, Boissiere F, Hibner U, et al. (1997): Expression of Bcl-2 in adult human brain regions with special reference to neurodegenerative disorders. J Neurochem 69:223-231.
17. Glantz LA, Gilmore JH, Lieberman JA, Jarskog LF (2006): Apoptotic mechanisms and the synaptic pathology of schizophrenia. Schizophr Res 81:47-63.
18. Chen G, Zeng WZ, Yuan PX, Huang LD, Jiang YM, Zhao ZH, et al. (1999): The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein Bcl-2 in the CNS. J Neurochem 72:879-882.
19. Moore GJ, Bebchuk JM, Wilds IB, Chen G, Manji HK (2000): Lithiuminduced increase in human brain grey matter. Lancet 356:1141-1142.
20. Moore GJ, Bebchuk JM, Hasanat K, Chen G, Seraji-Bozorgzad N, Wilds IB, et al. (2000): Lithium increases N-acetyl-aspartate in the human brain: In vivo evidence in support of Bcl-2's neurotrophic effects? Biol Psychiatry 48:1-8.